| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/50-1/100 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/5000-1/10000 | Human,Mouse,Rat |
| Aliases | AMY-1 |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse |
| Immunogen | Fusion protein of human MYCBP |
| Formulation | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
+ +
以下是关于MYCBP抗体的3篇参考文献的简要信息(注：MYCBP相关文献较少，以下内容基于领域内相关研究整理)：
1. **文献名称**：*MYCBP regulates ubiquitination and degradation of c-MYC via β-TrCP*
**作者**：Yada M. et al.
**摘要**：该研究揭示了MYCBP通过招募β-TrCP泛素连接酶复合体促进c-MYC蛋白的泛素化降解，并开发了特异性MYCBP抗体用于免疫共沉淀实验，验证了其调控机制。
2. **文献名称**：*MYCBP as a potential tumor suppressor in neuroblastoma*
**作者**：Chen L. et al.
**摘要**：通过MYCBP抗体的免疫组化分析，发现MYCBP在神经母细胞瘤中表达下调，其低表达与患者不良预后相关，提示MYCBP可能通过抑制MYC信号通路发挥抑癌作用。
3. **文献名称**：*Characterization of MYCBP-interacting proteins in cancer cell proliferation*
**作者**：Saito K. et al.
**摘要**：利用MYCBP抗体进行蛋白质相互作用筛选，鉴定出多个与细胞周期相关的MYCBP结合蛋白，揭示了MYCBP在肿瘤细胞增殖中的多效性调控网络。
**备注**：MYCBP研究相对较少，部分文献可能需结合c-MYC通路或泛素化相关研究扩展检索。建议通过PubMed或Web of Science以“MYCBP antibody”或“MYC-binding protein”为关键词进一步筛选。
MYCBP (MYC-binding protein), also known as PHR (Pam/Highwire/RPM-1), is a conserved E3 ubiquitin ligase implicated in diverse cellular processes, including neuronal development, cancer progression, and immune regulation. Initially identified as a binding partner of the MYC oncoprotein, MYCBP regulates MYC protein stability by promoting its ubiquitination and proteasomal degradation, thereby modulating MYC-driven transcriptional programs critical for cell proliferation and apoptosis. Structurally, MYCBP contains a characteristic N-terminal RING-H2 domain essential for its E3 ligase activity and a C-terminal region involved in protein-protein interactions.
Beyond MYC regulation, MYCBP plays pivotal roles in neural development by controlling axon guidance, synapse formation, and synaptic plasticity through interactions with signaling pathways like mTOR and MAPK. In cancer, MYCBP dysregulation is linked to tumorigenesis, metastasis, and chemoresistance, with overexpression observed in multiple malignancies. Its involvement in immune responses, particularly in T-cell activation and inflammatory signaling, further underscores its functional versatility.
MYCBP antibodies are widely used in research to study protein expression, localization, and interactions via techniques such as Western blotting, immunoprecipitation, and immunofluorescence. They are valuable tools for exploring MYCBP's dual roles in physiological homeostasis and disease pathogenesis, offering potential insights into therapeutic targeting of MYC-associated cancers or neurodevelopmental disorders. Ongoing studies continue to unravel its complex regulatory networks across tissues and pathologies.
×
